$ASND 3 SEC Filings

Filed On	Filing
01 Apr 2026	Form 3: Bienaime Jean Jacques, Director Holds 0 shares of Ordinary Shares
18 Mar 2026	Form 3: Fairey William, Director Holds 2,117 shares of Ordinary Shares
18 Mar 2026	Form 3: Imani Siham, Director Holds 2,317 shares of Ordinary Shares
18 Mar 2026	Form 3: Smith Scott Thomas, EVP & Chief Financial Officer Holds 2,517 shares of Ordinary Shares
18 Mar 2026	Form 3: Jensen Michael Wolff, EVP, Chief Legal Officer
18 Mar 2026	Form 3: Bodenhoff Mads, SVP & PAO
18 Mar 2026	Form 3: Pedersen Anni Lotte Kirstine Sonderbjerg, EVP & Chief Admin Officer Holds 19,460 shares of Ordinary Shares
18 Mar 2026	Form 3: Morrison Lisa, Director Holds 1,572 shares of Ordinary Shares
18 Mar 2026	Form 3: Holtug Lars, Director Holds 4,236 shares of Ordinary Shares
18 Mar 2026	Form 3: Sprogoe Kennett, See Remarks Holds 19,460 shares of Ordinary Shares
18 Mar 2026	Form 3: Wu Jay Donovan, EVP & President US Market Holds 1,068 shares of Ordinary Shares
18 Mar 2026	Form 3: Mikkelsen Jan Moller, Director Holds 384,933 shares of Ordinary Shares
18 Mar 2026	Form 3: Jensen Flemming Steen, See Remarks Holds 19,460 shares of Ordinary Shares
18 Mar 2026	Form 3: Cha Albert, Director Holds 3,730 shares of Ordinary Shares
18 Mar 2026	Form 3: Shu Aimee, EVP & Chief Medical Officer Holds 0 shares of Ordinary Shares

Comments